Connable Office’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Connable Office's NVS Position: Q3 2026 in Review
Connable Office held its Novartis (NVS) position steady in Q3 2026 at 8,946 shares worth $1.28M. The position accounts for 0.11% of the portfolio, ranked #83.
Connable Office first reported a position in NVS in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.46M in Q3 2016. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Connable Office held 8,946 shares of Novartis worth $1.28M as of Q3 2026.
- Connable Office left its Novartis share count unchanged in Q3 2026.
- Novartis made up 0.11% of Connable Office's portfolio in Q3 2026, its #83 holding.
- Connable Office first reported a position in Novartis in Q2 2013 and has held it in 19 quarters since.
- Connable Office's Novartis position peaked at $3.46M in Q3 2016.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Connable Office's 13F filing for Q3 2026, filed 10 Nov 2026.